Home Neuronal Signaling 5-HT Receptor agonist Zolmitriptan For research use only.

Zolmitriptan

Synonyms: BW-311C90

Zolmitriptan(BW-311C90) is a novel and highly selective 5-HT(1B/1D) receptor agonist, used in the treatment of acute migraines.

Zolmitriptan Chemical Structure

Zolmitriptan Chemical Structure

CAS No. 139264-17-8

Purity & Quality Control

Zolmitriptan Related Products

Signaling Pathway

5-HT Receptor Signaling Pathways

5-HT Receptor Signaling Pathway

Biological Activity

Description Zolmitriptan(BW-311C90) is a novel and highly selective 5-HT(1B/1D) receptor agonist, used in the treatment of acute migraines.
Targets
5-HT [1]
In vitro
In vitro

Zolmitriptan produces concentration-dependent contractions of primate basilar artery and human epicardial coronary artery rings. Zolmitriptan displays high affinity at human recombinant 5-HT1D (formerly 5-HT1D alpha) and 5-HT1B (formerly 5-HT1D beta) receptors in transfected CHO-K1 cell membranes. [1] Zolmitriptan increases I(K) in a concentration-dependent manner (maximum increase 16.3%) with a pD(2) value of 7.03 in C6 glioma cells expressing recombinant human 5-HT(1B) receptor. Zolmitriptan-induced increases in I(K) are prevented by the calcium chelator, EGTA (5 mM) when included in the patch pipette in C6 cells expressing cloned human 5-HT(1B) receptors. [2]
In Vivo
In vivo

Zolmitriptan (3-30 mg/kg, i.v.) administrated ten minutes before unilateral electrical stimulation of the trigeminal ganglion causes a dose-dependent inhibition of [125I]-albumin extravasation within the ipsilateral dura mater in anaesthetized guinea-pigs. [1] Zolmitriptan (10-1000 mg/kg, i.v.) selectively reduces arteriovenous-anastomotic (AVA) conductance producing a maximum decrease of 92.5%. Zolmitriptan also produces a modest reduction in extra-cerebral conductance (23.9% maximum reduction at 30 mg/kg, i.v.), but is without effect on cerebral conductance. Zolmitriptan (1-30 mg/kg, i.v.) produces dose-dependent decreases in ear microvascular conductance (15% to 60%) which mirror decreases in carotid arterial conductance in anaesthetised cats. [3] Zolmitriptan exerts behaviorally specific anti-aggressive effects in mice. Zolmitriptan also decreases alcohol-heightened aggression with equal efficacy in mice. [4]
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06074016 Completed
Healthy
Parc de Salut Mar|Food and Drug Administration (FDA)
 July 12 2023 Phase 1
NCT05019430 Recruiting
Cocaine Use Disorder
William Stoops|National Institute on Drug Abuse (NIDA)|University of Kentucky
 October 15 2021 Early Phase 1
NCT01085123 Completed
Migraine
AstraZeneca
 May 2010 Phase 1
NCT00637286 Completed
Migraine
AstraZeneca
 July 2004 Phase 4

Chemical Information & Solubility

Molecular Weight 287.36 Formula

C16H21N3O2
CAS No. 139264-17-8 SDF Download Zolmitriptan SDF
Smiles CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3
Storage (From the date of receipt)

In vitro
Batch:

DMSO : 58 mg/mL ( (201.83 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 58 mg/mL

Water : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Zolmitriptan | Zolmitriptan ic50 | Zolmitriptan price | Zolmitriptan cost | Zolmitriptan solubility dmso | Zolmitriptan purchase | Zolmitriptan manufacturer | Zolmitriptan research buy | Zolmitriptan order | Zolmitriptan mouse | Zolmitriptan chemical structure | Zolmitriptan mw | Zolmitriptan molecular weight | Zolmitriptan datasheet | Zolmitriptan supplier | Zolmitriptan in vitro | Zolmitriptan cell line | Zolmitriptan concentration | Zolmitriptan nmr